Markets
Leaderboard
Will Alzheimer's disease nasal spray vaccine be safe in humans by the end of 2023? No: real money —, play money 58% Yes: real money —, play money 42% Volume: real money 96.61603, play money 11360 Bettors: real money 0, play money 19 Categories: Science, Alzheimer's disease Related markets Bumetanide considered effective in the treatment of genetic Alzheimer's by the end of 2026? (ID: 188267) Volume: real 637.48699985, play 18164.13138258 Bettors: real 9, play 34 Leading (real money): Bumetanide considered effective in the treatment of genetic Alzheimer's by the end of 2026? 14% Leading (play money): Bumetanide considered effective in the treatment of genetic Alzheimer's by the end of 2026? 24% Any vaccine against Alzheimer's disease to be safe and effective by the end of 2027? (ID: 188266) Volume: real 471.62892348, play 49845.09429936 Bettors: real 14, play 91 Leading (real money): Any vaccine against Alzheimer's disease to be safe and effective by the end of 2027? 35% Leading (play money): Any vaccine against Alzheimer's disease to be safe and effective by the end of 2027? 16%

Will Alzheimer's disease nasal spray vaccine be safe in humans by the end of 2023?

Market Rules

Researchers at the Brigham and Women Hospital (USA) are testing a spray vaccine against Alzheimer's Disease. Phase I clinical trials are intended to assess the safety of the immunizer that is designed to prevent and slow the progression of Alzheimer's.

The clinical trial will assess the effect of two doses of the formula in 16 participants with a confirmed diagnosis for the disease. By the time this market was published, however, the official date for the first volunteers to receive the immunizing agent had not yet been announced.

If the nasal spray vaccine against Alzheimer's Disease developed by researchers from the Brigham and Women Hospital proves to be safe in humans by the end of 2023, and clinical trials advance to phase II, this market will resolve to “Yes”.

This market will be resolved based on news (with verifiable sources) and scientific studies on the subject from sources or publications that Futuur finds credible and reputable, such as, but not restricted to, World Health Organization, Nature Magazine, Science and other specialized scientific journals.

Related Markets